Correlation with BMI z-score 1) | |||||
---|---|---|---|---|---|
Without MS | With MS | P 2) | WHO | CDC | |
Number of participants (%) | 185 (75.2) | 61 (24.8) | - | - | - |
Females, n (%) | 97 (52.4) | 25 (41.0) | 0.141 | - | - |
Pubertal Stage (pre-pub (%))3) | 30 (16.2) | 8 (13.1) | 0.684 | - | - |
Age (years) | 12.7 ± 1.8 | 13.4 ± 2.1 | 0.017 | 0.057 | 0.122 |
Height (cm) | 158.5 ± 8.9 | 162.8 ± 9.9 | 0.002 | 0.189** | 0.277** |
Weight (kg) | 78.0 (68.0-89.0) | 90.2 (76.0-113.5) | <0.001 | 0.673** | 0.726** |
BMI (kg/m2) | 30.55 (28.15-34.08) | 34.52 (30.20-39.14) | <0.001 | 0.848** | 0.865** |
BMI z-score (CDC) | 2.20 ± 0.29 | 2.43 ± 0.31 | <0.001 | 0.933** | - |
BMI z-score (WHO) | 3.00 ± 0.62 | 3.51 ± 0.86 | <0.001 | - | 0.933** |
Waist circumference (cm) | 99.0 (91.8-106.5) | 105.0 (96.5-118.0) | <0.001 | 0.736** | 0.778** |
Waist / Height | 0.630 ± 0.066 | 0.668 ± 0.081 | 0.002 | 0.794** | 0.783** |
Blood pressure | |||||
Systolic (mmHg)4) | 116 ± 12 | 135 ± 13 | <0.001 | 0.323** | 0.360** |
Diastolic (mmHg)4) | 63 ± 8 | 70 ± 12 | 0.001 | 0.267** | 0.218** |
Lipid profile | |||||
TG (mg/dl) | 71.0 (53.1-100.6) | 126.7 (81.5-181.5) | <0.001 | 0.186** | 0.185** |
HDLc (mg/dl) | 43.0 (38.3-49.0) | 35.0 (32.0-38.4) | <0.001 | −0.215** | −0.223** |
TC (mg/dl) | 150.8 (134.5-174.0) | 164.0 (142.0-189.2) | 0.038 | 0.105 | 0.084 |
LDLc (mg/dl) | 92.0 (76.0-109.8) | 101.0 (83.5-119.4) | 0.055 | 0.145* | 0.126* |
Glucose metabolism | |||||
Glucose (mg/dl) | 83.0 (77.0-89.6) | 88.0 (80.0-93.8) | 0.005 | 0.043 | 0.046 |
Insulin (μU/ml) | 15.9 (12.2-22.1) | 23.3 (14.6-33.3) | <0.001 | 0.421** | 0.440** |
HOMA-IR | 3.18 (2.43-4.52) | 4.94 (3.34-7.06) | <0.001 | 0.410** | 0.429** |
Inflammatory mediator | |||||
CRP (mg/l)5) | 1.61 (0.84-4.05) | 2.30 (1.00-4.59) | 0.072 | 0.326** | 0.302** |